{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:37:05Z","timestamp":1763987825749},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T00:00:00Z","timestamp":1505692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T00:00:00Z","timestamp":1505692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HORM CANC"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12672-017-0307-4","type":"journal-article","created":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T15:09:57Z","timestamp":1505747397000},"page":"314-324","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Inhibitory Effects of Antagonists of Growth Hormone-Releasing Hormone (GHRH) in Thyroid Cancer"],"prefix":"10.1007","volume":"8","author":[{"given":"Helena","family":"P\u00f3pulo","sequence":"first","affiliation":[]},{"given":"Bruno","family":"Nunes","sequence":"additional","affiliation":[]},{"given":"Cristina","family":"Sampaio","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Batista","sequence":"additional","affiliation":[]},{"given":"Marta Teixeira","family":"Pinto","sequence":"additional","affiliation":[]},{"given":"Tiago B.","family":"Gaspar","sequence":"additional","affiliation":[]},{"given":"Leandro","family":"Miranda-Alves","sequence":"additional","affiliation":[]},{"given":"Ren-Zhi","family":"Cai","sequence":"additional","affiliation":[]},{"given":"Xian Yang","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Andrew V.","family":"Schally","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Sobrinho-Sim\u00f5es","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Soares","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2017,9,18]]},"reference":[{"key":"307_CR1","doi-asserted-by":"publisher","first-page":"11866","DOI":"10.1073\/pnas.182433099","volume":"99","author":"R Busto","year":"2002","unstructured":"Busto R, Schally AV, Varga JL, Garcia-Fernandez MO, Groot K, Armatis P, Szepeshazi K (2002) The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas. Proc Natl Acad Sci U S A 99:11866\u201311871","journal-title":"Proc Natl Acad Sci U S A"},{"key":"307_CR2","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s12672-015-0217-2","volume":"6","author":"P Catanuto","year":"2015","unstructured":"Catanuto P, Tashiro J, Rick FG, Sanchez P, Solorzano CC, Glassberg MK, Block NL, Lew JI, Elliot SJ, Schally AV (2015) Expression of receptors for pituitary-type growth hormone-releasing hormone (pGHRH-R) in human papillary thyroid cancer cells: effects of GHRH antagonists on matrix Metalloproteinase-2. Horm Cancer 6:100\u2013106","journal-title":"Horm Cancer"},{"key":"307_CR3","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1073\/pnas.1323102111","volume":"111","author":"CD Fahrenholtz","year":"2014","unstructured":"Fahrenholtz CD, Rick FG, Garcia MI, Zarandi M, Cai RZ, Block NL, Schally AV, Burnstein KL (2014) Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer. Proc Natl Acad Sci U S A 111:1084\u20131089","journal-title":"Proc Natl Acad Sci U S A"},{"key":"307_CR4","doi-asserted-by":"publisher","first-page":"E1139","DOI":"10.1210\/jc.2011-2748","volume":"97","author":"A Faustino","year":"2012","unstructured":"Faustino A, Couto JP, Populo H, Rocha AS, Pardal F, Cameselle-Teijeiro JM, Lopes JM, Sobrinho-Simoes M, Soares P (2012) mTOR pathway overactivation in BRAF mutated papillary thyroid carcinoma. J Clin Endocrinol Metab 97:E1139\u2013E1149","journal-title":"J Clin Endocrinol Metab"},{"key":"307_CR5","doi-asserted-by":"publisher","first-page":"17424","DOI":"10.1073\/pnas.0506844102","volume":"102","author":"A Havt","year":"2005","unstructured":"Havt A, Schally AV, Halmos G, Varga JL, Toller GL, Horvath JE, Szepeshazi K, Koster F, Kovitz K, Groot K, Zarandi M, Kanashiro CA (2005) The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues. Proc Natl Acad Sci U S A 102:17424\u201317429","journal-title":"Proc Natl Acad Sci U S A"},{"key":"307_CR6","first-page":"137","volume":"33","author":"F Hohla","year":"2008","unstructured":"Hohla F, Moder A, Mayrhauser U, Hauser-Kronberger C, Schally AV, Varga JL, Zarandi M, Buchholz S, Huber R, Aigner E, Ritter M, Datz C (2008) Differential expression of GHRH receptor and its splice variant 1 in human normal and malignant mucosa of the oesophagus and colon. Int J Oncol 33:137\u2013143","journal-title":"Int J Oncol"},{"key":"307_CR7","doi-asserted-by":"publisher","first-page":"9512","DOI":"10.1073\/pnas.1533185100","volume":"100","author":"H Kiaris","year":"2003","unstructured":"Kiaris H, Chatzistamou I, Schally AV, Halmos G, Varga JL, Koutselini H, Kalofoutis A (2003) Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor. Proc Natl Acad Sci U S A 100:9512\u20139517","journal-title":"Proc Natl Acad Sci U S A"},{"key":"307_CR8","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/cncr.26291","volume":"118","author":"A Klukovits","year":"2012","unstructured":"Klukovits A, Schally AV, Szalontay L, Vidaurre I, Papadia A, Zarandi M, Varga JL, Block NL, Halmos G (2012) Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers. Cancer 118:670\u2013680","journal-title":"Cancer"},{"key":"307_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrc1836","volume":"6","author":"T Kondo","year":"2006","unstructured":"Kondo T, Ezzat S, Asa SL (2006) Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6:292\u2013306","journal-title":"Nat Rev Cancer"},{"key":"307_CR10","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/j.peptides.2010.07.006","volume":"31","author":"M Kovacs","year":"2010","unstructured":"Kovacs M, Schally AV, Hohla F, Rick FG, Pozsgai E, Szalontay L, Varga JL, Zarandi M (2010) A correlation of endocrine and anticancer effects of some antagonists of GHRH. Peptides 31:1839\u20131846","journal-title":"Peptides"},{"key":"307_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods 25:402\u2013408","journal-title":"Methods"},{"key":"307_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/mc.20042","volume":"41","author":"E Miyagi","year":"2004","unstructured":"Miyagi E, Braga-Basaria M, Hardy E, Vasko V, Burman KD, Jhiang S, Saji M, Ringel MD (2004) Chronic expression of RET\/PTC 3 enhances basal and insulin-stimulated PI3 kinase\/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells. Mol Carcinog 41:98\u2013107","journal-title":"Mol Carcinog"},{"key":"307_CR13","doi-asserted-by":"publisher","first-page":"18303","DOI":"10.1073\/pnas.1421815112","volume":"111","author":"YJ Qin","year":"2014","unstructured":"Qin YJ, Chan SO, Chong KK, Li BF, Ng TK, Yip YW, Chen H, Zhang M, Block NL, Cheung HS, Schally AV, Pang CP (2014) Antagonist of GH-releasing hormone receptors alleviates experimental ocular inflammation. Proc Natl Acad Sci U S A 111:18303\u201318308","journal-title":"Proc Natl Acad Sci U S A"},{"key":"307_CR14","doi-asserted-by":"publisher","first-page":"10561","DOI":"10.1073\/pnas.180313297","volume":"97","author":"Z Rekasi","year":"2000","unstructured":"Rekasi Z, Czompoly T, Schally AV, Halmos G (2000) Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers. Proc Natl Acad Sci U S A 97:10561\u201310566","journal-title":"Proc Natl Acad Sci U S A"},{"key":"307_CR15","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1073\/pnas.1018086108","volume":"108","author":"FG Rick","year":"2011","unstructured":"Rick FG, Schally AV, Block NL, Nadji M, Szepeshazi K, Zarandi M, Vidaurre I, Perez R, Halmos G, Szalontay L (2011) Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia. Proc Natl Acad Sci U S A 108:3755\u20133760","journal-title":"Proc Natl Acad Sci U S A"},{"key":"307_CR16","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1073\/pnas.1120588109","volume":"109","author":"FG Rick","year":"2012","unstructured":"Rick FG, Schally AV, Szalontay L, Block NL, Szepeshazi K, Nadji M, Zarandi M, Hohla F, Buchholz S, Seitz S (2012) Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases. Proc Natl Acad Sci U S A 109:1655\u20131660","journal-title":"Proc Natl Acad Sci U S A"},{"key":"307_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0092-8674(00)80226-3","volume":"89","author":"P Rodriguez-Viciana","year":"1997","unstructured":"Rodriguez-Viciana P, Warne PH, Khwaja A, Marte BM, Pappin D, Das P, Waterfield MD, Ridley A, Downward J (1997) Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457\u2013467","journal-title":"Cell"},{"key":"307_CR18","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3181\/00379727-119-30138","volume":"119","author":"AV Schally","year":"1965","unstructured":"Schally AV, Steelman SL, Bowers CY (1965) Effect of hypothalamic extracts on release of growth hormone in vitro. Proc Soc Exp Biol Med. Soc Exp Biol Med 119:208\u2013212","journal-title":"Proc Soc Exp Biol Med. Soc Exp Biol Med"},{"key":"307_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/ncpendmet0677","volume":"4","author":"AV Schally","year":"2008","unstructured":"Schally AV, Varga JL, Engel JB (2008) Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer. Nat Clin Pract Endocrinol Metab 4:33\u201343","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"307_CR20","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.4161\/cc.10.21.17904","volume":"10","author":"A Siejka","year":"2011","unstructured":"Siejka A, Barabutis N, Schally AV (2011) GHRH antagonist MZ-5-156 increases the expression of AMPK in A549 lung cancer cells. Cell Cycle 10:3714\u20133718","journal-title":"Cell Cycle"},{"key":"307_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2174\/157489212798358010","volume":"7","author":"A Siejka","year":"2012","unstructured":"Siejka A, Lawnicka H, Melen-Mucha G, Motylewska E, Komorowski J, Stepien H (2012) Antineoplastic action of growth hormone-releasing hormone (GHRH) antagonists. Recent Pat Anti-cancer Drug Discov 7:56\u201363","journal-title":"Recent Pat Anti-cancer Drug Discov"},{"key":"307_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.clon.2010.05.004","volume":"22","author":"JA Sipos","year":"2010","unstructured":"Sipos JA, Mazzaferri EL (2010) Thyroid cancer epidemiology and prognostic variables. Clin Oncol 22:395\u2013404","journal-title":"Clin Oncol"},{"key":"307_CR23","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1210\/me.2005-0001","volume":"20","author":"G Siriwardana","year":"2006","unstructured":"Siriwardana G, Bradford A, Coy D, Zeitler P (2006) Autocrine\/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase. Mol Endocrinol 20:2010\u20132019","journal-title":"Mol Endocrinol"},{"key":"307_CR24","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.4161\/15384101.2015.945879","volume":"13","author":"L Szalontay","year":"2014","unstructured":"Szalontay L, Schally AV, Popovics P, Vidaurre I, Krishan A, Zarandi M, Cai RZ, Klukovits A, Block NL, Rick FG (2014) Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function. Cell Cycle 13:2790\u20132797","journal-title":"Cell Cycle"},{"key":"307_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.peptides.2017.01.009","volume":"89","author":"M Zarandi","year":"2017","unstructured":"Zarandi M, Cai R, Kovacs M, Popovics P, Szalontay L, Cui T, Sha W, Jaszberenyi M, Varga J, Zhang X, Block NL, Rick FG, Halmos G, Schally AV (2017) Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth. Peptides 89:60\u201370","journal-title":"Peptides"},{"key":"307_CR26","doi-asserted-by":"publisher","first-page":"12298","DOI":"10.1073\/pnas.91.25.12298","volume":"91","author":"M Zarandi","year":"1994","unstructured":"Zarandi M, Horvath JE, Halmos G, Pinski J, Nagy A, Groot K, Rekasi Z, Schally AV (1994) Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone. Proc Natl Acad Sci U S A 91:12298\u201312302","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Hormones and Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12672-017-0307-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-017-0307-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-017-0307-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T17:12:11Z","timestamp":1609261931000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12672-017-0307-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,18]]},"references-count":26,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["307"],"URL":"https:\/\/doi.org\/10.1007\/s12672-017-0307-4","relation":{},"ISSN":["1868-8497","1868-8500"],"issn-type":[{"value":"1868-8497","type":"print"},{"value":"1868-8500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,18]]},"assertion":[{"value":"13 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}